Clinical Diagnosis

High-level observations for how the latest developments can help glaucoma specialists solve problems to achieve the utmost in patient care

There are other mimickers of NTG that should be kept in mind

New products increase the chance of early diagnosis

New therapies on the horizon offer options for slowing progression

Novel technologies range from invasive to non-invasive approaches

A team of researchers at the University of Alberta believe a case of pink eye is now a reason to be tested for COVID-19.

Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.